Study tests smarter HIV prevention for LGBTQ+ people struggling with addiction
NCT ID NCT05934877
First seen Feb 18, 2026 · Last updated May 16, 2026 · Updated 11 times
Summary
This study aimed to help HIV-negative transgender women and men who have sex with men who also have a substance use disorder stay on PrEP, a daily pill that prevents HIV. Participants received counseling and text support, with extra help for those still struggling. The study was ended early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Friends Community Center
Los Angeles, California, 90038, United States
Conditions
Explore the condition pages connected to this study.